Barentz, a leading provider of ingredients in the global market for human nutrition, pharmaceuticals, personal care and animal nutrition, announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies.
- Barentz has a strong market position in a structurally growing market for life science ingredients
- The Cinven team knows the speciality ingredients distribution market well
- Cinven recognizes the opportunities for both organic and buy and build growth
- Financial terms of the transaction are not disclosed
Headquartered in the Netherlands, Barentz distributes ingredients and additives for products to both small, medium and large customers globally. The company sources branded speciality ingredients from manufacturers worldwide. Through its active production facilities in Europe, North America and Asia, Barentz’ ingredient experts provide value-added technical support including pre-mixing, blending, ingredient formulation and ingredient testing.
Considering the distribution business is a structurally growing market, Barentz wants to continue to expand in order to serve their suppliers and customers on a global scale.
Hidde van der Wal, CEO of Barentz, commented:
‘We are delighted to be working with Cinven on the next phase of our growth. The Cinven team has really impressed us with their understanding of our market and their strong track record of growing businesses internationally.’
‘In particular, their investment and support for our business strategy will enable us to expand our operations into new geographic markets, including through acquisition, and will ensure we have the right infrastructure to achieve this.’
Ben Osnabrug, partner at Cinven, said:
‘Barentz has a strong presence in a structurally growing market. The Cinven team knows the speciality distribution sector well, with the key trends driving the growth of the food and life sciences ingredients market including a shift towards natural ingredients, increased demand for customised formulations, and a growing share of manufacturers using distributors to drive market access and to improve efficiencies.’
‘Cinven’s investment in Barentz resulted from a combination of our detailed sub-sector approach within Business Services, and our regional network in the Netherlands, and we are delighted to invest in this primary opportunity. In particular, Barentz has an excellent management team whom we can back to pursue both organic and buy and build growth.’
For more information, please contact:
Elisabeth Roest Kempemo, Director Marketing & Communication
firstname.lastname@example.org, tel +31 6 17174989
Saturnusstraat 15, 2132 HB Hoofddorp, The Netherlands
Cinven is a leading international private equity firm focused on building world-class European and global companies. Its Funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT). Cinven has offices in London, Frankfurt, Paris, Milan, Madrid, Guernsey, Luxembourg, Hong Kong and New York. Cinven takes a responsible approach towards its portfolio companies; their employees, suppliers and local communities; the environment and society. For more information, please visit www.cinven.com
Barentz is a leading global provider of ingredients for the life sciences markets. Representing world-class suppliers, Barentz offers customers a comprehensive portfolio of speciality ingredients, including unique specialty ingredients and blends from Barentz-owned production companies, all supported by the best technical teams and top-of-the-line application labs. Barentz commitment to quality was recently recognized with an award at CFIA France 2018. Barentz (established in 1953) operates in more than 60 countries and employs more than 1,100 people worldwide. To learn more, visit www.barentz.com.